Last reviewed · How we verify
Inactivated influenza split vaccine — Competitive Intelligence Brief
marketed
Biologic
Live · refreshed every 30 min
Target snapshot
Inactivated influenza split vaccine (Inactivated influenza split vaccine) — St. Petersburg Research Institute of Vaccines and Sera.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Inactivated influenza split vaccine TARGET | Inactivated influenza split vaccine | St. Petersburg Research Institute of Vaccines and Sera | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Inactivated influenza split vaccine CI watch — RSS
- Inactivated influenza split vaccine CI watch — Atom
- Inactivated influenza split vaccine CI watch — JSON
- Inactivated influenza split vaccine alone — RSS
Cite this brief
Drug Landscape (2026). Inactivated influenza split vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/inactivated-influenza-split-vaccine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab